Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


04 marzo 2013

Direct carotid access “offers the best of both worlds”

Interventional News

At the LINC congress, Sumaira Macdonald, Freeman Hospital, Newcastle, UK, spoke about the new MICHI (Silk Road Medical) direct carotid access system, presented data to support the technique and stated that this system integrates the benefits of both carotid endarterectomy and carotid artery stenting.

25 febrero 2013

NIH-funded study confirms consistently good acute stroke outcomes with Penumbra System

Neuro News

On 13 February 2013 Joseph Broderick University of Cincinnati, USA, and principle investigator of the Interventional Management of Stroke III (IMS III) trial, announced the overall results and major subgroup analyses at the International Stroke Conference in Honolulu, Hawaii. Thomas Tomsick, principle investigator and primary interventional investigator announced results comparing outcomes by intra-arterial approach.

01 marzo 2013

Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain

Healthcare Sales & Marketing Network

Kimberly-Clark today announced the publication of two separate studies that achieved positive outcomes following use of cooled radiofrequency (RF) to treat discogenic and sacroiliac joint (SIJ) pain in the low back. The studies evaluated Kimberly-Clark s TransDiscal Cooled Radiofrequency System and SInergy Cooled Radiofrequency System and demonstrated that both treatment options provided patients who suffer from chronic low back pain with much-needed pain relief and improved quality of life benefits. Results were published in Pain Medicine, the official journal of the American Academy of Pain Medicine, the Faculty of Pain Medicine of the Australian and New Zealand College of Anesthetists, and the International Spine Intervention Society

28 febrero 2013

InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study

Healthcare Sales & Marketing Network

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced the Company has submitted an updated Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) requesting permission to begin human studies in order to test its biopolymer scaffolding for the treatment of acute SCI

21 febrero 2013

Cooling the brain may prevent trauma-induced epilepsy

Neuro News

A new study in rats suggests that gently cooling the brain after injury may prevent patients often experience epileptic seizures that are difficult to control in weeks, months and years after severe head injury. The researchers reported their findings in Annals of Neurology.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.